Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel probe medicament combination and preparation method and application thereof

A drug and probe technology, which is applied in the new probe drug combination, preparation and application fields, can solve the problem of not being able to specifically reflect the drug metabolism ability of the liver and the like

Inactive Publication Date: 2009-12-09
娄建石
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although there are many clinical indicators used to check liver function, they cannot specifically reflect the drug metabolism ability of the liver. Therefore, the "cocktail" method is used to quantitatively measure the activity of metabolic enzymes in the body to study the effect of liver disease status on the activity of drug metabolism enzymes. It can estimate the possible toxic reaction caused by the traditional drug dose, adjust the clinical drug regimen, and has important significance in alleviating the adverse drug reaction and guiding clinical rational drug use.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel probe medicament combination and preparation method and application thereof
  • Novel probe medicament combination and preparation method and application thereof
  • Novel probe medicament combination and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0236] Accurately weigh 5mg of probe drug caffeine and 20mg of metoprolol dissolved in 6ml of normal saline, weigh 10mg of chlorzoxazone and 5mg of tolbutamide and dissolve in 2ml of absolute ethanol, slowly add absolute ethanol to the normal saline Then, accurately draw 2ml (10mg) of midazolam injection and add to the above mixture to prepare a "cocktail" probe solution. The solution was prepared freshly before administration and used immediately after preparation.

Embodiment 2

[0238] Accurately weigh 5mg of probe drug caffeine and 50mg of metoprolol dissolved in 6ml of normal saline, weigh 30mg of chlorzoxazone and 5mg of tolbutamide and dissolve in 2ml of absolute ethanol, slowly add absolute ethanol to the normal saline Then, accurately draw 2ml (10mg) of midazolam injection and add to the above mixture to prepare a "cocktail" probe solution. The solution was prepared freshly before administration and used immediately after preparation.

Embodiment 3

[0240] Accurately weigh 15mg of probe drug caffeine and 20mg of metoprolol dissolved in 6ml of normal saline, weigh 20mg of chlorzoxazone and 15mg of tolbutamide and dissolve in 2ml of absolute ethanol, slowly add absolute ethanol to the normal saline Then, accurately draw 30 mg of midazolam injection and add it to the above mixture to prepare a "cocktail" probe solution. The solution was prepared freshly before administration and used immediately after preparation.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a novel cocktail probe medicament combination comprising caffeine, metoprolol, chlorzoxazone, tolbutamide and midazolam. The influence of hepatic ischemia preconditioning and hepatic ischemia-reperfu-sion injury on medicament metabolism activity of rat CYP1A2, CYP2C9, CYP2E1, CYP2D6, and CYP3A4 in vivo is evaluated through the change of pharmacokinetics parameters of the combination.

Description

technical field [0001] The present invention relates to the field of medicine, in particular to a new "cocktail" probe pharmaceutical composition, which can be used to evaluate the effects of hepatic ischemic preconditioning and hepatic ischemia-reperfusion injury on rat CYP subtypes through the changes of its pharmacokinetic parameters Effects of CYP1A2, CYP2C9, CYP2E1, CYP2D6, and CYP3A4 on drug metabolism activity in vivo. Background technique [0002] Many exogenous substances (xenobiotics) need to undergo biotransformation in the body, and the liver is the main place where the human body undergoes biotransformation phase I reactions. Enzymes involved in biotransformation are a mixed-function oxidase system that relies on cytochrome P450 and is regulated by a huge gene family, the main component of which is cytochrome P450 (CYP) enzyme system. CYP is divided into 17 gene families, 42 subfamilies, and 64 enzymes in humans. Among them, functional enzymes closely related ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K49/00
Inventor 娄建石刘颖焦建杰张才丽
Owner 娄建石
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com